The determination of thyroid hormones and autoantibodies to identify comorbidity (Hashimoto’s thyroiditis) is recommended, as patients with csU are more often affected by autoimmune thyroid diseases [12]. This evidence concerns the gene TG and Hashimoto thyroiditis.